LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,916,000 | -28.9% | 150,376 | -2.4% | 0.43% | -25.0% |
| Q4 2021 | $23,791,000 | +34.5% | 154,026 | +21.3% | 0.58% | +22.9% |
| Q3 2021 | $17,685,000 | +5.2% | 126,941 | -0.9% | 0.47% | -0.4% |
| Q2 2021 | $16,811,000 | +37.0% | 128,140 | +59.2% | 0.47% | +33.1% |
| Q1 2021 | $12,272,000 | -34.5% | 80,500 | -57.3% | 0.35% | -42.4% |
| Q4 2020 | $18,727,000 | +13.6% | 188,306 | +8.9% | 0.61% | -13.2% |
| Q3 2020 | $16,481,000 | -14.9% | 172,906 | -0.1% | 0.71% | -19.5% |
| Q2 2020 | $19,365,000 | +55.4% | 173,132 | +1.1% | 0.88% | +23.7% |
| Q1 2020 | $12,458,000 | – | 171,315 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |